Criminal Code Regulations 2019 (Cth)

Criminal Code Regulations 2019

made under the

Criminal Code Act 1995

Compilation No. 5

Compilation date:1 March 2025

Includes amendments:F2025L00032

About this compilation

This compilation

This is a compilation of the Criminal Code Regulations 2019 that shows the text of the law as amended and in force on 1 March 2025 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Register ( The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the Register for the compiled law.

Self‑repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

Contents

Part 1Preliminary1Name

This instrument is the Criminal Code Regulations 2019.

3Authority

This instrument is made under the Criminal Code Act 1995.

4Definitions

In this instrument:
AFP member has the same meaning as in Part 5.3 of the Code.
authorised person means a person who is an authorised person for the purposes of regulation 5 of the Customs (Prohibited Imports) Regulations 1956.
chief executive officer of a legal aid commission of a State or Territory means the person holding, or performing the duties of, the following position:
(a)
for New South Wales, Victoria, Queensland and the Australian Capital Territory—Chief Executive Officer of the legal aid commission of that State or Territory;
(b)
for Western Australia—Director of Legal Aid under the Legal Aid Commission Act 1976 (WA);
(c)
for South Australia—Director of Legal Services under the Legal Services Commission Act 1977 (SA);
(d)
for Tasmania—Director of the Commission under the Legal Aid Commission Act 1990 (Tas.);
(e)
for the Northern Territory—Director of Legal Aid under the Legal Aid Act1990 (NT).
Code means the Criminal Code.
control order has the same meaning as in Part 5.3 of the Code.
Health Secretary means the Secretary of the Department administered by the Minister administering the Therapeutic Goods Act 1989.
issuing court has the same meaning as in Part 5.3 of the Code.
lawyer has the same meaning as in Part 5.3 of the Code.
legal aid commission means an authority established by or under a law of a State or Territory for the purpose of providing legal assistance.
young person means a person who is at least 14 but under 18.

Part 2The security of the CommonwealthDivision 1Control orders5Legal representation for young people

For the purposes of subsection 104.28(6) of the Code, this Division provides in relation to the appointing of a lawyer to act for a young person in relation to proceedings relating to a control order.

6Court may request legal aid commission to arrange representation

An issuing court may request a legal aid commission to arrange the legal representation of a young person in proceedings relating to a control order.

7AFP to inform relevant persons of request and contact details

(1)
This section applies if an issuing court requests a legal aid commission under section 6 to arrange the legal representation of a young person in proceedings relating to a control order.
Informing the legal aid commission
(2)
An AFP member, or a legal representative of the Australian Federal Police, must:
1. (a)
  in writing, inform the chief executive officer of the legal aid commission of the request; and
2. (b)
  give the legal aid commission the following information that the AFP member or legal representative has:
  1. (i)
    the young person’s name;
  2. (ii)
    the young person’s residential address;
  3. (iii)
    the young person’s contact details, including a telephone number and an email address;
  4. (iv)
    the young person’s date of birth;
  5. (v)
    the name, residential address and contact details of at least one parent or guardian of the young person;
  6. (vi)
    if the young person requires assistance with communication—information about the assistance required.
  Note: For subparagraph (b)(vi), a young person may need assistance with communication because, for example, the person is deaf or hearing impaired, is unable to read, has a mental impairment, or requires an interpreter.
Informing the young person
(3)
An AFP member, or a legal representative of the Australian Federal Police, must:
1. (a)
  inform the young person of the request; and
2. (b)
  give the young person sufficient information about the legal aid commission to enable the young person to contact and, if necessary, attend the legal aid commission, including the following information that the AFP member or legal representative has:
  1. (i)
    the name of the legal aid commission;
  2. (ii)
    the legal aid commission’s business address (not being a post box);
  3. (iii)
    the legal aid commission’s contact details, including a telephone number and an email address;
  4. (iv)
    any other information about the legal aid commission provided by the issuing court; and
3. (c)
  ensure that the young person understands the information provided to them under paragraphs (a) and (b) (taking into account the person’s age, language skills, mental capacity and any other relevant factor).
(4)
Subsection (3) does not apply if the actions of the young person make it impracticable for the AFP member or legal representative to comply with that subsection.
Informing a parent or guardian of the young person
(5)
An AFP member, or a legal representative of the Australian Federal Police, must take reasonable steps to:
1. (a)
  inform at least one parent or guardian of the young person of the request; and
2. (b)
  give the parent or guardian the information about the legal aid commission that is required to be provided to the young person under paragraph (3)(b).
Timing
(6)
An AFP member or legal representative of the Australian Federal Police complying with subsection (2), (3) or (5) must do so as soon as practicable after the issuing court makes the request and at least 48 hours before the next day when the court will conduct proceedings relating to the control order.

Division 2Preventative detention orders8Corresponding State preventative detention laws

For the purposes of the definition of corresponding State preventative detention law in subsection 100.1(1) of the Code, the following are declared to correspond to Division 105 of the Code:
(a)
Part 2A of the Terrorism (Police Powers) Act 2002 (NSW);
(b)
Part 2A of the Terrorism (Community Protection) Act 2003 (Vic.);
(c)
the Terrorism (Preventative Detention) Act 2005 (Qld);
(d)
the Terrorism (Preventative Detention) Act 2006 (WA);
(e)
the Terrorism (Preventative Detention) Act 2005 (SA);
(f)
the Terrorism (Preventative Detention) Act 2005 (Tas.);
(g)
Part 2 of the Terrorism (Extraordinary Temporary Powers) Act 2006 (ACT);
(h)
Part 2B of the Terrorism (Emergency Powers) Act 2003 (NT).

Division 3Continuing detention orders9Terrorist offender unable to engage legal representative in continuing detention order proceedings – matters court may take into account in determining whether circumstances beyond offender’s control

For the purposes of paragraph 105A.15A(3)(a) of the Code, the following matters are prescribed as matters that a Supreme Court of a State or Territory may take into account in determining whether circumstances are beyond an offender’s control in relation to a continuing detention order proceeding:
(a)
the offender’s financial circumstances;
(b)
whether the offender has engaged in unreasonable conduct during the proceeding that has contributed to the offender’s inability to afford any or all of the costs and expenses of obtaining legal representation for the proceeding;
(c)
whether the offender has made any efforts to obtain legal aid or legal assistance, and the outcomes of any such efforts;
(d)
any other matter that the Court considers relevant.

10Sharing information – prescribed persons

For the purposes of subsections 105A.19(1) and (3) of the Code, the following persons are prescribed:
(a)
an AFP employee (within the meaning of the Australian Federal Police Act 1979);
(b)
a member of the police force or police service of a State or Territory;
(c)
an officer or employee of a State or Territory, or of an authority of a State or Territory, whose duties relate to corrective services (including prison medical, psychological and psychiatric services), justice or parole;
(d)
a person who provides services for, or on behalf of:
(i)
a State or Territory; or
(ii)
an authority of a State or Territory;
in relation to corrective services (including prison medical, psychological and psychiatric services), justice or parole;
(da)
a person who provides services for, or on behalf of, the Commonwealth in relation to a person (the service recipient) if:
(i)
a post‑sentence order or an interim post‑sentence order is in force in relation to the service recipient; or
(ii)
the AFP Minister has made, or is considering making, an application for a post‑sentence order or an interim post‑sentence order in relation to the service recipient;
(e)
the Director of Public Prosecutions or a person performing a similar function under a law of a State or Territory;
(f)
a member of the staff of the Office of the Director of Public Prosecutions (within the meaning of the Director of Public Prosecutions Act 1983) or of a similar body established under a law of a State or Territory;
(g)
the Director‑General of Security, a Deputy Director‑General of Security, an ASIO employee (within the meaning of the Australian Security Intelligence Organisation Act 1979) or an ASIO affiliate (within the meaning of that Act);
(h)
an APS employee of a Department administered by the Minister administering:
(i)
the Migration Act 1958; or
(ii)
the Australian Citizenship Act 2007; or
(iii)
the Australian Passports Act 2005;
(i)
a person:
(i)
who is an authorised officer (within the meaning of Division 9A of Part IB of the Crimes Act 1914); or
(ii)
who, under a delegation from such an authorised officer, exercises powers or performs functions of the authorised officer under Division 9A of Part IB of the Crimes Act 1914;
(j)
a person who is a relevant expert and who is:
(i)
appointed by the AFP Minister under section 105A.18D of the Code; or
(ii)
otherwise engaged, by the AFP Minister, or a person on behalf of the AFP Minister;
to assess the risk of a terrorist offender committing a serious Part 5.3 offence (all within the meaning of Division 105A of the Code) for the purposes of that Division (whether or not an application for a post‑sentence order has been made).

Part 3Dangers to the communityDivision 1Serious drugs and precursors11Controlled drugs

Each item of the table in clause 1 of Schedule 1 lists:
(a)
for the purposes of paragraph 301.1(1)(a) of the Code, a substance that is a controlled drug; and
(b)
for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity that is the commercial quantity of the controlled drug; and
(c)
for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity (if any) that is the marketable quantity of the controlled drug; and
(d)
for the purposes of paragraph (a) of item 1 of the table in section 301.12 of the Code, the quantity that is the trafficable quantity of the controlled drug.

12Controlled plants

Each item of the following table lists:
(a)
for the purposes of paragraph 301.2(1)(a) of the Code, a growing plant that is a controlled plant; and
(b)
for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, a quantity that is a commercial quantity of the controlled plant; and
(c)
for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, a quantity that is a marketable quantity of the controlled plant; and
(d)
for the purposes of paragraph (a) of item 1 of the table in section 301.12 of the Code, a quantity that is a trafficable quantity of the controlled plant.

Controlled plants and quantities
1	Any plant of the genus Cannabis	250 kg or 1,000 plants	25 kg or 100 plants	250 g or 10 plants

Controlled plants and quantities

Item

Controlled plant

Commercial quantity

Marketable quantity

Trafficable quantity

Any plant of the genus Cannabis

250 kg or

1,000 plants

25 kg or

100 plants

250 g or

10 plants

13Controlled precursors

Each item of the following table lists:
(a)
for the purposes of paragraph 301.3(1)(a) of the Code, a substance that is a controlled precursor; and
(b)
for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity that is the commercial quantity of the controlled precursor; and
(c)
for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity that is the marketable quantity of the controlled precursor.
Note: A salt or ester of a substance listed in the table is also a controlled precursor: see paragraph 301.3(1)(b) of the Code.

Controlled precursors and quantities
Item	Controlled precursor	Commercial quantity (kilograms)	Marketable quantity (grams)
1A	Alpha‑Phenylacetoacetamide (APAA)	2.75	915.0
1B	Alpha‑Phenylacetoacetonitrile (APAAN)	1.76	587.0
1C	4‑Anilino‑N‑phenethylpiperidine (ANPP)	0.006	2.77
1D	Butyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate	1.46	292.0
1E	Butyl 3‑phenyl‑2‑methyl glycidate	3.61	1,194.0
1F	Diethyl 2‑(2‑phenylacetyl)propanedioate (DEPAPD)	4.75	1,585.0
1	Ephedrine	1.2	400.0
2	Ergometrine	0.006	0.15
3	Ergotamine	0.01	0.25
3A	Ethyl alpha‑phenylacetoacetate (EAPA)	3.28	1,094.0
3B	Ethyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate	1.3	261.0
3C	Ethyl 3‑phenyl‑2‑methyl glycidate	3.18	1,051.0
3D	Isobutyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate	1.46	292.0
3E	Isobutyl 3‑phenyl‑2‑methyl glycidate	3.61	1,194.0
3F	Isopropyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate	1.38	275.0
3G	Isopropyl 3‑phenyl‑2‑methyl glycidate	3.39	1,123.0
4	Isosafrole	1.45	290.0
5	Lysergic acid	0.003	0.075
5A	Methyl alpha‑phenylacetoacetate (MAPA)	3.06	1,020.0
6	3,4‑Methylenedioxyphenylacetic acid	1.5	300.0
6AA	3‑(3’,4’‑Methylenedioxyphenyl)‑2‑methyl glycidic acid	1.33	266.0
6A	3‑(3’, 4’‑Methylenedioxyphenyl)‑2‑methyl glycidic acid, sodium salt (NaMDMG)	1.46	292.0
7	3,4‑Methylenedioxyphenyl‑2‑propanone	0.75	150.0
7A	Methyl 3‑(3’, 4’‑methylenedioxyphenyl)‑2‑methyl glycidate (MMDMG)	1.23	246.0
7B	Methyl 3‑phenyl‑2‑methyl glycidate	2.96	980.0
7BA	Norfentanyl	0.006	2.8
7C	N‑Phenethyl‑4‑piperidone (NPP)	0.008	4.0
8	Phenylacetic acid	4.05	1,350.0
8AA	3‑Phenyl‑2‑methyl glycidic acid	4.6	1,531.0
8A	3‑Phenyl‑2‑methyl glycidic acid, sodium salt	5.17	1,720.0
8B	N‑Phenyl‑4‑piperidinamine (4‑AP)	0.008	3.8
9	Phenylpropanolamine	1.2	400.0
10	Phenyl‑2‑propanone	1.04	340.0
10A	Phenyl‑2‑propanone bisulphite	2.64	880.0
10B	1‑Phenylpropan‑2‑yl 4‑methylbenzenesulfonate (para‑tosyl‑phenyl‑2‑propanol)	2.25	737.0
10C	4‑Piperidone	0.008	3.8
11	Piperonal	1.6	320.0
11A	Propyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate	1.38	275.0
11B	Propyl 3‑phenyl‑2‑methyl glycidate	3.39	1,123.0
12	Pseudoephedrine	1.2	400.0
13	Safrole	2.85	570.0
14	sec‑Butyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate	1.46	292.0
15	sec‑Butyl 3‑phenyl‑2‑methyl glycidate	3.61	1,194.0
16	N‑(tert‑Butoxycarbonyl)‑4‑piperidone	0.015	7.6
17	tert‑Butyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate	1.46	292.0
18	tert‑Butyl 4‑(phenylamino)piperidine‑1‑carboxylate (1‑boc‑4‑AP)	0.015	7.3
19	tert‑Butyl 3‑phenyl‑2‑methyl glycidate	3.61	1,194.0

14Border controlled drugs

(1)
Each item of the table in subclause 1(1) of Schedule 2 lists:
1. (a)
  for the purposes of paragraph 301.4(1)(a) of the Code, a substance that is a border controlled drug; and
2. (b)
  for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity that is the commercial quantity of the border controlled drug; and
3. (c)
  for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity that is the marketable quantity of the border controlled drug.
Restricted listing
(2)
Each item of the table in subclause 1(2) of Schedule 2 lists:
1. (a)
  for the purposes of paragraph 301.4(1)(a) and subsection 301.4(2) of the Code, a substance that is taken to be a border controlled drug only in relation to the following:
  1. (i)
    an offence against subsection 307.1(1), 307.2(1), 307.3(1) or 307.4(1) of the Code, if the offence relates to importing a substance;
  2. (ii)
    an offence against subsection 307.5(1), 307.6(1), 307.7(1), 307.8(1), 307.9(1) or 307.10(1) of the Code;
  3. (iii)
    an offence against subsection 309.12(1) or 309.13(1) of the Code, if the offence relates to procuring an individual to import a substance; and
2. (b)
  for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity that is the commercial quantity of the border controlled drug; and
3. (c)
  for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity that is the marketable quantity of the border controlled drug.

15Border controlled plants

Each item of the following table lists:
(a)
for the purposes of paragraph 301.5(1)(a) of the Code, a growing plant that is a border controlled plant; and
(b)
for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, a quantity (if any) that is a commercial quantity of the border controlled plant; and
(c)
for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, a quantity (if any) that is a marketable quantity of the border controlled plant.

Border controlled plants and quantities
Item	Border controlled plant	Commercial quantity	Marketable quantity
1	Any plant of the genus Cannabis	250 kg or 1,000 plants	25 kg or 100 plants
2	Any plant of the genus Erythroxylon (also known as Erythroxylum) from which cocaine can be extracted either directly or by chemical transformation	80 kg
3	Any plant of the genus Lophophora
4	Any plant of the species Papaver bracteatum	10 kg
5	Any plant of the species Papaver somniferum	10 kg
6	Any plant of the species Piptagenia peregrine
7	Any plant of the species Psilocybe

16Border controlled precursors

(1)
Each item of the following table lists:
1. (a)
  for the purposes of paragraph 301.6(1)(a) of the Code, a substance that is a border controlled precursor; and
2. (b)
  for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity (if any) that is the commercial quantity of the border controlled precursor; and
3. (c)
  for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity (if any) that is the marketable quantity of the border controlled precursor.
Note: A salt or ester of a substance listed in the table and an immediate precursor of a substance listed in the table are also border controlled precursors: see paragraphs 301.6(1)(b) and (c) of the Code.

Border controlled precursors and quantities
Item	Border controlled precursor	Commercial quantity (kilograms)	Marketable quantity (grams)
1	N‑Acetylanthranilic acid
1A	Alpha‑Phenylacetoacetamide (APAA)	2.74	7.3
1B	Alpha‑Phenylacetoacetonitrile (APAAN)	1.76	4.7
1C	4‑Anilino‑N‑phenethylpiperidine (ANPP)	0.006	0.006
2	Any plant of the species Ephedra
2AA	Butyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate	1.46	14.6
2AB	Butyl 3‑phenyl‑2‑methyl glycidate	3.61	9.6
2A	Chloroephedrine	1.153	3.07
2B	Chloropseudoephedrine	1.153	3.07
2C	Diethyl 2‑(2‑phenylacetyl)propanedioate (DEPAPD)	4.75	12.7
3	Ephedrine	1.2	3.2
4	Ergometrine	0.006	0.006
5	Ergotamine	0.01	0.01
5A	Ethyl alpha‑phenylacetoacetate (EAPA)	3.28	8.8
5B	Ethyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate	1.3	13.0
5C	Ethyl 3‑phenyl‑2‑methyl glycidate	3.18	8.5
5D	Isobutyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate

1.46	14.6
5E	Isobutyl 3‑phenyl‑2‑methyl glycidate	3.61	9.6
5F	Isopropyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate	1.38	13.8
5G	Isopropyl 3‑phenyl‑2‑methyl glycidate	3.39	9.1
6	Isosafrole	1.45	1.45
7	Lysergic acid	0.003	0.003
7A	Methyl alpha‑phenylacetoacetate (MAPA)	3.06	8.2
7AA	3‑(3’,4’‑Methylenedioxyphenyl)‑2‑methyl glycidic acid	1.33	13.3
7B	3‑(3’, 4’‑Methylenedioxyphenyl)‑2‑methyl glycidic acid, sodium salt (NaMDMG)	1.46	14.6
8	3,4‑Methylenedioxyphenyl‑2‑propanone	0.75	0.75
8A	Methyl 3‑(3’, 4’‑methylenedioxyphenyl)‑2‑methyl glycidate (MMDMG)	1.23	12.3
8B	Methyl 3‑phenyl‑2‑methyl glycidate	2.96	7.9
8BA	Norfentanyl	0.006	0.006
8C	N‑Phenethyl‑4‑piperidone (NPP)	0.008	0.008
9	Phenylacetic acid	4.05	10.8
9AA	3‑Phenyl‑2‑methyl glycidic acid	4.6	12.2
9A	3‑Phenyl‑2‑methyl glycidic acid, sodium salt	5.17	13.7
9B	N‑Phenyl‑4‑piperidinamine (4‑AP)	0.008	0.008
10	Phenylpropanolamine	1.2	3.2
11	Phenyl‑2‑propanone	1.04	2.7
11A	Phenyl‑2‑propanone bisulphite	2.64	7.04
11B	1‑Phenylpropan‑2‑yl 4‑methylbenzenesulfonate (para‑tosyl‑phenyl‑2‑propanol)	2.25	5.9
11C	4‑Piperidone	0.008	0.008
12	Piperonal	1.6	1.6
12A	Propyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate	1.38	13.8
12B	Propyl 3‑phenyl‑2‑methyl glycidate	3.39	9.1
13	Pseudoephedrine	1.2	3.2
14	Safrole	2.85	2.85
15	sec‑Butyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate	1.46	14.6
16	sec‑Butyl 3‑phenyl‑2‑methyl glycidate	3.61	9.6
17	N‑(tert‑Butoxycarbonyl)‑4‑piperidone	0.015	0.015
18	tert‑Butyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate	1.46	14.6
19	tert‑Butyl 4‑(phenylamino) piperidine‑1‑carboxylate (1‑boc‑4‑AP)	0.015	0.015
20	tert‑Butyl 3‑phenyl‑2‑methyl glycidate	3.61	9.6

Restricted listing
(2)
Each item of the following table lists:
(a)
for the purposes of paragraph 301.6(1)(a) and subsection 301.6(1A) of the Code, a substance that is taken to be a border controlled precursor only in relation to the following:
(i)
an offence against subsection 307.11(1), 307.12(1) or 307.13(1) of the Code, if the offence relates to importing a substance;
(ii)
an offence against subsection 309.14(1) or 309.15(1) of the Code, if the offence relates to procuring an individual to import a substance; and
(b)
for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity that is the commercial quantity of the border controlled precursor; and
(c)
for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity that is the marketable quantity of the border controlled precursor.
Note: For a salt, ester or immediate precursor of a substance listed in the table, see paragraphs 301.6(1)(b) and (c) and subsection 301.6(1B) of the Code.

Border controlled precursors and quantities—restricted listing
Item	Border controlled precursor	Commercial quantity (kilograms)	Marketable quantity (grams)
1	Alpha‑Methyl‑1,3‑benzodioxole‑5‑propanal (Helional)	1.0	1.0
2	Benzaldehyde	1.85	4.8
3	Hypophosphorous acid (Phosphinic acid)	1.2	3.2
4	Iodine	1.2	3.2
5	Methylamine	0.6	1.6

Division 2Psychoactive substances17Importing psychoactive substances

For the purposes of paragraph 320.2(2)(l) of the Code, a substance that is imported into Australia in accordance with the conditions set out in section 19 of this instrument is prescribed.

18Importing substances represented to be serious drug alternatives

For the purposes of paragraph 320.3(3)(f) of the Code, a substance that is imported into Australia in accordance with the conditions set out in section 19 of this instrument is prescribed.

19Conditions for importing certain substances

(1)
For the purposes of sections 17 and 18, the conditions are that:
1. (a)
  the person importing the substance (the importer) is the holder of a licence to import drugs granted by the Health Secretary or an authorised person under subregulation 5(5) of the Customs (Prohibited Imports) Regulations 1956; and
2. (b)
  the importer is covered by subsection (2); and
3. (c)
  before the substance is imported, the importer gives the Health Secretary or an authorised person a written notice about the proposed importation that includes:
  1. (i)
    the identity and amount of the substance being imported; and
  2. (ii)
    the purpose of the importation; and
  3. (iii)
    a 30‑day period during which the importation is likely to occur; and
  4. (iv)
    the importer’s name and import licence number; and
  5. (v)
    if paragraph (2)(a), (d), (e) or (f) applies and the importer is employed by the body mentioned in the applicable paragraph—the name of the importer’s employer; and
  6. (vi)
    any other information required by the Health Secretary.
(2)
For the purposes of paragraph (1)(b), the importer is covered by this subsection if:
1. (a)
  the importer is, or is employed by, a forensic laboratory and is importing the substance for the purposes of forensic analysis; or
2. (b)
  the importer is the Australian Federal Police, or a police force of a State or Territory, and is importing the substance for the purposes of law enforcement; or
3. (c)
  the importer is the Commissioner or a Deputy Commissioner of the Australian Federal Police, or is the head or deputy head (however described) of a police force of a State or Territory, and is importing the substance for the purposes of law enforcement; or
4. (d)
  the importer is, or is employed by, a medical research facility and is importing the substance for the purposes of medical research; or
5. (e)
  the importer is, or is employed by, a scientific research facility and is importing the substance for the purposes of scientific research; or
6. (f)
  all of the following apply:
  1. (i)
    the importer is, or is employed by, an entity that imports drugs (within the meaning of subregulation 5(20) of the Customs (Prohibited Imports) Regulations 1956) on behalf of a person or body mentioned in paragraph (a), (b), (c), (d) or (e);
  2. (ii)
    the person or body holds a licence of a kind mentioned in paragraph (1)(a);
  3. (iii)
    the importer is importing the substance at the written request of the person or body.
(3)
For the purposes of paragraph (1)(c), the Health Secretary may determine:
1. (a)
  information to be included in a notice; and
2. (b)
  the way a notice may be given to the Health Secretary or an authorised person.

Division 3Cross‑border firearms trafficking20Firearm law

For the purposes of the definition of firearm law in subsections 360.2(3) and 360.3(2) of the Code, the following laws are prescribed:
(a)
the Firearms Act 1996 (NSW);
(b)
the Firearms Act 1996 (Vic.);
(c)
the Weapons Act 1990 (Qld);
(d)
the Firearms Act 1973 (WA);
(e)
the Firearms Act 2015 (SA);
(f)
the Firearms Act 1996 (Tas.);
(g)
the Firearms Act 1996 (ACT);
(h)
the Firearms Act 1997 (NT);
(i)
the Firearms and Prohibited Weapons Act 1997 (Norfolk Island);
(j)
any regulations made under any of the Acts referred to in paragraphs (a) to (i).

Division 4Community safety orders20ASerious offender unable to engage legal representative in community safety order proceedings – matters court may take into account in determining whether circumstances beyond offender’s control

For the purposes of paragraph 395.34(3)(a) of the Code, the following matters are prescribed as matters that a Supreme Court of a State or Territory may take into account in determining whether circumstances are beyond a serious offender’s control in relation to a community safety order proceeding:
(a)
the offender’s financial circumstances;
(b)
whether the offender has engaged in unreasonable conduct during the proceeding that has contributed to the offender’s inability to afford any or all of the costs and expenses of obtaining legal representation for the proceeding;
(c)
whether the offender has made any efforts to obtain legal aid or legal assistance, and the outcomes of any such efforts;
(d)
any other matter that the Court considers relevant.

20BSharing information – prescribed persons

For the purposes of subsections 395.44(1) and (4) of the Code, the following persons are prescribed:
(a)
an AFP employee (within the meaning of the Australian Federal Police Act 1979);
(b)
a member of the police force or police service of a State or Territory;
(c)
an officer or employee of a State or Territory, or of an authority of a State or Territory, whose duties relate to corrective services (including prison medical, psychological and psychiatric services), justice or parole;
(d)
a person who provides services for, or on behalf of:
(i)
a State or Territory; or
(ii)
an authority of a State or Territory;
in relation to corrective services (including prison medical, psychological and psychiatric services), justice or parole;
(e)
a person who provides services for, or on behalf of, the Commonwealth in relation to a person (the service recipient) if:
(i)
a community safety order is in force in relation to the service recipient; or
(ii)
the Immigration Minister has made, or is considering making, an application for a community safety order in relation to the service recipient;
(f)
the Director of Public Prosecutions or a person performing a similar function under a law of a State or Territory;
(g)
a member of the staff of the Office of the Director of Public Prosecutions (within the meaning of the Director of Public Prosecutions Act 1983) or of a similar body established under a law of a State or Territory;
(h)
the Director‑General of Security, a Deputy Director‑General of Security, an ASIO employee (within the meaning of the Australian Security Intelligence Organisation Act 1979) or an ASIO affiliate (within the meaning of that Act);
(i)
an APS employee in a Department administered by:
(i)
the Immigration Minister; or
(ii)
the Minister administering the Australian Passports Act 2005;
(j)
a person:
(i)
who is an authorised officer (within the meaning of Division 9A of Part IB of the Crimes Act 1914); or
(ii)
who, under a delegation from such an authorised officer, exercises powers or performs functions of the authorised officer under Division 9A of Part IB of the Crimes Act 1914;
(k)
a person who is a relevant expert and who is:
(i)
appointed by the Immigration Minister under section 395.43 of the Code; or
(ii)
otherwise engaged by the Immigration Minister, or a person on behalf of the Immigration Minister;
to assess the risk of a serious offender committing a serious violent or sexual offence for the purposes of Division 395 of the Code (whether or not an application for a community safety order has been made);
(l)
a person who is engaged as a consultant or contractor to perform services for the Department administered by the Immigration Minister;
(m)
a person who is:
(i)
engaged or employed by a person to whom paragraph (l) or this paragraph applies; and
(ii)
performing services for the Department administered by the Immigration Minister in connection with that engagement or employment.

Part 4National infrastructure21Dangerous or harmful substances and things that must not be carried by post

For the purposes of subparagraph 471.15(1)(b)(ii) of the Code, the following are dangerous or harmful substances or things that must not, without exception, be carried by post:
(a)
gas that is so toxic or corrosive to humans as to pose a hazard to health;
(b)
a thermally unstable substance that is likely to undergo a strongly exothermic decomposition;
(c)
a substance that ignites or self‑heats when in contact with air.

Part 5Application, saving and transitional provisionsDivision 1Provisions for this instrument as originally made22Things done under the Criminal Code Regulations 2002

(1)
If:
1. (a)
  a thing was done for a particular purpose under the Criminal Code Regulations 2002 as in force immediately before those Regulations were repealed; and
2. (b)
  the thing could be done for that purpose under this instrument;
the thing has effect for the purposes of this instrument as if it had been done for that purpose under this instrument.
(2)
Without limiting subsection (1), a reference in that subsection to a thing being done includes a reference to a notice, application or other instrument being given or made.

23Conduct, event, circumstances occurring before commencement

(1)
To avoid doubt, a function or duty may be performed, or a power exercised, under this instrument in relation to conduct engaged in, an event that occurred, or a circumstance that arose, before this section commences.
(2)
This section does not limit section 22 of this instrument or section 7 of the Acts Interpretation Act 1901 (as that Act applies in relation to this instrument because of paragraph 13(1)(a) of the Legislation Act 2003).

Schedule 1Controlled drugs

Note: See section 11.

1Controlled drugs and quantities

The following table lists substances that are controlled drugs and the quantities of those drugs that are commercial quantities, marketable quantities and trafficable quantities.
Note: A drug analogue of a substance listed in the table is also a controlled drug (see paragraph 301.1(1)(b) of the Code).

Controlled drugs and quantities
Item	Controlled drug	Commercial quantity (kilograms)	Marketable quantity (grams)	Trafficable quantity (grams)
1	Acetorphine	2.0	250.0	2.0
2	4‑Acetoxy‑N, N‑dimethyltryptamine (4‑AcO‑DMT)	2.0	250.0	2.0
3	4‑Acetoxy‑N‑methyl‑N‑ethyltryptamine (4‑AcO‑MET)	2.0	250.0	2.0
4	Acetyl‑alpha‑methylfentanyl	0.005	2.5	0.005
5	Acetylcodeine	2.0	250.0	2.0
6	Acetyldihydrocodeine	2.0	250.0	2.0
7	Acetylmethadol	2.0	250.0	2.0
8	Allylprodine	2.0	250.0	2.0
9	Alphacetylmethadol	10.0	5,000.0	10.0
10	Alphameprodine	0.2	100.0	0.2
11	Alphamethadol	0.2	100.0	0.2
12	alpha‑Methylfentanyl	0.005	2.5	0.005
13	alpha‑Methylthiofentanyl	0.005	2.5	0.005
14	Alphaprodine	25.0	12,500.0	25.0
15	alpha‑Pyrrolidinobutiophenone (α‑PBP)	0.75	250.0	0.75
16	alpha‑Pyrrolidinopropiophenone (α‑PPP)	0.75	250.0	0.75
17	alpha‑Pyrrolidinovalerophenone (α‑PVP)	0.75	250.0	0.75
18	5‑(2‑Aminopropyl)‑2,3‑dihydro‑1h‑indene (5‑APDI)	0.75	250.0	0.75
19	6‑(2‑Aminopropyl)‑2,3‑dihydrobenzofuran (6‑APDB)	0.75	250.0	0.75
20	Amphetamine	0.75	250.0	2.0
21	Anileridine	25.0	12,500.0	25.0
22	Barbiturates	5.0	5.0
23	Benzethidine	10.0	5,000.0	10.0
24	1‑(Benzofuran‑6‑yl) propan‑2‑amine (6‑APB)	0.75	250.0	0.75
24A	Benzoylbenzylfentanyl	0.005	2.5	0.005
25	Benzoylecgonine	2.0	250.0	2.0
25A	Benzoylfentanyl	0.005	2.5	0.005
25B	Benzylfentanyl	0.005	2.5	0.005
25C	Benzylfuranylfentanyl	0.005	2.5	0.005
26	Benzylmorphine	5.0	2,500.0	5.0
27	Benzylpiperazine	0.75	250.0	2.0
28	Betacetylmethadol	5.0	2,500.0	5.0
29	beta‑Hydroxyfentanyl	0.005	2.5	0.005
30	beta‑Hydroxy‑3‑methylfentanyl	0.005	2.5	0.005
31	beta‑Keto‑methylbenzodioxolylpentanamine (pentylone)	0.75	250.0	0.75
32	beta‑Keto‑N‑methyl‑3,4‑ benzodioxyolylbutanamine (butylone)	0.75	250.0	0.75
33	Betameprodine	5.0	2,500.0	5.0
34	Betamethadol	5.0	2,500.0	5.0
35	Betaprodine	5.0	2,500.0	5.0
36	Bezitramide	5.0	2,500.0	5.0
36A	Bromazolam	5.0	1,250.0	30.0
37	2‑Bromoamphetamine	0.75	250.0	0.75
38	3‑Bromoamphetamine	0.75	250.0	0.75
39	4‑Bromoamphetamine	0.75	250.0	0.75
40	4‑Bromo‑2,5‑dimethoxyamphetamine	0.5	100.0	0.5
41	2‑Bromo‑5‑methoxymethcathinone	0.75	250.0	0.75
42	2‑Bromomethamphetamine	0.75	250.0	0.75
43	3‑Bromomethamphetamine	0.75	250.0	0.75
44	4‑Bromomethamphetamine	0.75	250.0	0.75
45	2‑Bromomethcathinone	0.75	250.0	0.75
46	3‑Bromomethcathinone	0.75	250.0	0.75
47	4‑Bromomethcathinone	0.75	250.0	0.75
48	Bufotenine	2.0	250.0	2.0
49	Bupropion	0.75	250.0	0.75
49A	Butonitazene	0.005	2.5	0.005
50	Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre)	125.0	25,000.0	250.0
51	Cannabis resin	125.0	25,000.0	20.0
52	Cathinone	0.75	250.0	0.75
53	1‑(4‑Chloro‑2,5‑dimethoxyphenyl)‑2‑ ethenamine (2C‑C)	0.5	100.0	0.5
54	2‑Chloroamphetamine	0.75	250.0	0.75
55	3‑Chloroamphetamine	0.75	250.0	0.75
56	4‑Chloroamphetamine	0.75	250.0	0.75
57	2‑Chloromethamphetamine	0.75	250.0	0.75
58	3‑Chloromethamphetamine	0.75	250.0	0.75
59	4‑Chloromethamphetamine	0.75	250.0	0.75
60	4‑Chloro‑N‑ethylamphetamine	0.75	250.0	0.75
61	2‑Chloromethcathinone	0.75	250.0	0.75
62	3‑Chloromethcathinone	0.75	250.0	0.75
63	4‑Chloromethcathinone	0.75	250.0	0.75
64	4‑Chlorophenyl‑1‑methoxypropan‑2‑amine	0.75	250.0	0.75
65	Chlorphentermine	2.0	250.0	2.0
66	Clonitazene	0.005	2.5	0.005
67	Cocaine	2.0	250.0	2.0
68	Codeine	10.0	5,000.0	10.0
69	Codeine‑N‑oxide	10.0	5,000.0	10.0
70	Codoxime	10.0	5,000.0	10.0
70A	N‑Desethyl etonitazene	0.005	2.5	0.005
70B	N‑Desethyl isotonitazene	0.005	2.5	0.005
70C	N‑Desethyl protonitazene	0.005	2.5	0.005
71	Desomorphine	2.0	250.0	2.0
72	Dexamphetamine	2.0	250.0	2.0
73	Dextromoramide	2.0	250.0	2.0
74	Diampromide	5.0	2,500.0	5.0
75	Diethylpropion (N, N‑Diethylcathinone)	5.0	2,500.0	5.0
76	Diethylthiambutene	5.0	2,500.0	5.0
77	N,N‑Diethyltryptamine	2.0	250.0	2.0
78	Difenoxin	2.0	250.0	2.0
79	1‑(2,3‑Dihydro‑1‑benzofuran‑5‑yl)propan‑2‑ amine (5‑APDB)	0.75	250.0	0.75
80	Dihydrocodeine	10.0	5,000.0	10.0
81	Dihydromorphine	10.0	5,000.0	10.0
82	Dimenoxadol	10.0	5,000.0	10.0
83	Dimepheptanol	10.0	5,000.0	10.0
84	2,5‑Dimethoxy‑4‑bromophenethylamine (2C‑B)	0.5	100.0	0.5
85	2,5‑Dimethoxy‑4‑ethylphenethylamine (2C‑E)	0.5	100.0	0.5
86	2,5‑Dimethoxy‑4‑iodophenethylamine (2C‑I)	0.5	100.0	0.5
87	2,5‑Dimethoxy‑4‑methylamphetamine (STP, DOM)	0.75	250	0.75
88	2,5‑Dimethoxy‑4‑methylphenethylamine (2C‑D)	0.5	100.0	0.5
89	2,5‑Dimethoxy‑4‑nitrophenethylamine (2C‑N)	0.5	100.0	0.5
90	2,5‑Dimethoxy‑4‑(n)‑propylphenethylamine (2C‑P)	0.5	100.0	0.5
91	3,4‑Dimethoxymethcathinone	0.75	250.0	0.75
92	1‑Dimethylamino‑1,2‑diphenylethane	5.0	2,500.0	5.0
93	N,N‑Dimethylamphetamine	0.75	250.0	0.75
94	N, N‑Dimethylcathinone	0.75	250.0	0.75
95	1,1‑Dimethylheptyl‑11‑ hydroxytetrahydrocannabinol (HU‑210)	5.0	1,000.0	5.0
96	3,4‑Dimethylmethcathinone	0.75	250.0	0.75
97	Dimethylthiambutene	20.0	10,000.0	20.0
98	N,N‑Dimethyltryptamine	2.0	250.0	2.0
99	Dioxaphetyl butyrate	2.0	250.0	2.0
99A	Dipentylone (N,N‑dimethylpentylone)	0.75	250.0	0.75
100	Diphenoxylate	2.0	250.0	2.0
101	Dipipanone	10.0	5,000.0	10.0
102	Drotebanol	2.0	250.0	2.0
103	Ecgonine	10.0	5,000.0	10.0
104	Ethchlorvynol	50.0	50.0
105	Ethinamate	50.0	50.0
106	N‑Ethylcathinone	0.75	250.0	0.75
106A	Ethylene etonitazene	0.005	2.5	0.005
106B	Ethyleneoxynitazene	0.005	2.5	0.005
107	Ethylmethylthiambutene	10.0	5,000.0	10.0
108	Ethylmorphine	2.0	250.0	2.0
109	3‑(2‑Ethylphenyl)‑2‑methyl‑quinazolin‑4‑one (Etaqualone)	5.0	5.0
109A	Etodesnitazene (etazene)	0.005	2.5	0.005
110	Etonitazene	0.005	2.5	0.005
110A	Etonitazepipne (N‑piperidinyl etonitazene)	0.005	2.5	0.005
110B	Etonitazepyne (N‑pyrrolidino etonitazene)	0.005	2.5	0.005
111	Etorphine	5.0	2,500.0	5.0
112	Etoxeridine	5.0	2,500.0	5.0
113	Fentanyl	0.005	2.5	0.005
113A	Flunitazene	0.005	2.5	0.005
114	4‑Fluoro‑2,5‑dimethoxyphenethylamine (2C‑F)	0.5	100.0	0.5
115	2‑Fluoroamphetamine	0.75	250.0	0.75
116	3‑Fluoroamphetamine	0.75	250.0	0.75
117	4‑Fluoroamphetamine	0.75	250.0	0.75
117A	2‑Fluorodeschloroketamine (2‑FDCK)	1.0	500.0	3.0
118	2‑Fluoromethamphetamine	0.75	250.0	0.75
119	3‑Fluoromethamphetamine	0.75	250.0	0.75
120	4‑Fluoromethamphetamine	0.75	250.0	0.75
121	2‑Fluoromethcathinone	0.75	250.0	0.75
122	3‑Fluoromethcathinone	0.75	250.0	0.75
123	4‑Fluoromethcathinone	0.75	250.0	0.75
123A	Furanylfentanyl	0.005	2.5	0.005
124	Furethidine	1.0	500.0	1.0
125	Gammabutyrolactone (GBL)	1.0	250.0	0.5
126	Glutethimide	50.0	50.0
127	Heroin (diacetylmorphine)	1.5	250.0	2.0
128	Hydrocodone	2.0	250.0	2.0
129	Hydromorphinol	2.0	250.0	2.0
130	Hydromorphone	2.0	250.0	2.0
131	Hydroxyamphetamine	2.0	250.0	2.0
132	4‑Hydroxybutanoic acid (GHB)	1.0	250.0	0.5
133	p‑Hydroxyephedrine	2.0	250.0	2.0
134	Hydroxypethidine	0.75	250.0	0.75
135	2‑Iodoamphetamine	0.75	250.0	0.75
136	3‑Iodoamphetamine	0.75	250.0	0.75
137	4‑Iodoamphetamine	0.75	250.0	0.75
138	2‑Iodomethamphetamine	0.75	250.0	0.75
139	3‑Iodomethamphetamine	0.75	250.0	0.75
140	4‑Iodomethamphetamine	0.75	250.0	0.75
141	2‑Iodomethcathinone	0.75	250.0	0.75
142	3‑Iodomethcathinone	0.75	250.0	0.75
143	4‑Iodomethcathinone	0.75	250.0	0.75
144	Isomethadone	2.0	250.0	2.0
145	4‑Isopropoxy‑2,5‑dimethoxyphenethylamine (2C‑O‑4)	0.5	100.0	0.5
145A	Isotodesnitazene	0.005	2.5	0.005
145B	Isotonitazene	0.005	2.5	0.005
146	Ketamine	1.0	500.0	3.0
147	Ketobemidone	2.0	250.0	2.0
148	Levomethorphan	2.0	250.0	2.0
149	Levophenacylmorphan	2.0	250.0	2.0
150	Levorphanol, but not including dextrorphan	1.0	500.0	1.0
151	Lysergamides	0.01	0.01
152	Lysergide (LSD)	0.002	0.05	0.002
153	Meprobamate	50.0	50.0
154	Mescaline	7.5	3.75	7.5
155	Metazocine	7.0	3,500.0	7.0
156	Methadone	2.0	250.0	2.0
157	Methamphetamine	0.75	250.0	2.0
158	Methaqualone	5.0	5.0
159	Methcathinone	0.75	250.0	2.0
160	Methorphan, but not including dextromethorphan	2.0	250.0	2.0
161	4’‑Methoxy‑alpha‑pyrrolidinopropiophenone (MOPPP)	0.75	250.0	0.75
162	4‑Methoxyamphetamine	0.75	250.0	0.75
163	4‑Methoxymethamphetamine	0.75	250.0	0.75
164	4‑Methoxymethcathinone	0.75	250.0	0.75
165	4’‑Methyl‑alpha‑pyrrolidinobutiophenone (MPBP)	0.75	250.0	0.75
166	4’‑Methyl‑alpha‑pyrrolidinohexiophenone (MPHP)	0.75	250.0	0.75
167	4’‑Methyl‑alpha‑pyrrolidinopropiophenone (MPPP)	0.75	250.0	0.75
168	2‑Methylamino‑1‑phenylbutan‑1‑ one (buphedrone)	0.75	250.0	0.75
169	4‑Methylamphetamine	0.75	250.0	0.75
170	N‑Methyl butylone	0.75	250.0	0.75
171	Methyldesorphine	2.0	250.0	2.0
172	Methyldihydromorphine	2.0	250.0	2.0
173	3,4‑Methylenedioxyamphetamine (MDA)	0.75	100.0	0.5
174	3,4‑Methylenedioxymethamphetamine (MDMA)

0.5	100.0	0.5
175	3,4‑Methylenedioxyethcathinone (MDEC)	0.75	250.0	0.75
176	3,4‑Methylenedioxymethcathinone (MDMC)	0.75	250.0	0.75
176A	Methylenedioxynitazene (2‑(2‑(benzo[d] [1,3]dioxol‑5‑ylmethyl)‑5‑nitro‑1H‑benzo [d]imidazol‑1‑yl)‑N,N‑diethylethan‑1‑amine)	0.005	2.5	0.005
177	3,4‑Methylenedioxypyrovalerone (MDPV)	0.75	250.0	0.75
178	3’,4’‑Methylenedioxy‑alpha‑ pyrrolidinobutiophenone (MDPBP)	0.75	250.0	0.75
179	3’,4’‑Methylenedioxy‑alpha‑ pyrrolidinopropiophenone (MDPPP)	0.75	250.0	0.75
180	4‑Methylethcathinone	0.75	250.0	0.75
181	3‑Methylfentanyl	0.005	2.5	0.005
182	4‑Methylmethamphetamine	0.75	250.0	0.75
183	4‑Methylmethcathinone (4‑MMC)	0.75	250.0	2.0
184	Methylphenidate	2.0	250.0	2.0
185	1‑Methyl‑4‑phenyl‑4‑propionoxypiperidine (MPPP)	2.0	250.0	2.0
186	4‑Methylthioamphetamine (4‑MTA)	0.75	250.0	0.75
187	4‑Methylthiobutylamphetamine (4‑MTBA)	0.75	250.0	0.75
188	4‑Methylthiodimethamphetamine (4‑MTDMA)	0.75	250.0	0.75
189	4‑Methylthioethylamphetamine (4‑MTEA)	0.75	250.0	0.75
190	3‑Methylthiofentanyl	0.005	2.5	0.005
191	4‑Methylthiomethamphetamine (4‑MTMA)	0.75	250.0	0.75
192	4‑Methylthiopropylamphetamine (4‑MTPA)	0.75	250.0	0.75
193	Methyprylon	50.0	50.0
193A	Metodesnitazene (metazene)	0.005	2.5	0.005
193B	Metonitazene	0.005	2.5	0.005
194	Metopon	2.0	250.0	2.0
195	Monoacetylmorphines	2.0	250.0	2.0
196	Moramide	2.0	250.0	2.0
197	Morphan, but not including dextrorphan	2.0	250.0	2.0
198	Morpheridine	2.0	250.0	2.0
199	Morphine	1.5	250.0	1.5
200	Morphine‑N‑oxide	2.0	250.0	2.0
201	Myrophine	20.0	20.0
202	Nicocodine	2.0	250.0	2.0
203	Nicodicodine	2.0	250.0	2.0
204	Nicomorphine	2.0	250.0	2.0
205	Noracymethadol	2.0	250.0	2.0
206	Norcodeine	2.0	250.0	2.0
207	Norlevorphanol	2.0	250.0	2.0
208	Normethadone	5.0	2,500.0	5.0
209	Normorphine	20.0	20.0
210	Norpipanone	10.0	5,000.0	10.0
211	Opium	20.0	10,000.0	20.0
212	Oripavine	2.0	250.0	2.0
213	Oxycodone	5.0	2,500.0	5.0
214	Oxymorphone	2.0	250.0	2.0
215	para‑Fluorofentanyl	0.005	2.5	0.005
216	Pentazocine	20.0	20.0
217	Pethidine	10.0	5,000.0	10.0
218	Phenadoxone	10.0	5,000.0	10.0
219	Phenampromide	10.0	5,000.0	10.0
220	Phenazocine	1.0	500.0	1.0
221	Phencyclidine	2.0	250.0	2.0
222	Phendimetrazine	5.0	2,500.0	5.0
223	Phenmetrazine	5.0	2,500.0	5.0
224	Phenomorphan	5.0	2,500.0	5.0
225	Phenoperidine	1.0	500.0	1.0
226	Phentermine	5.0	2,500.0	5.0
227	1‑Phenylethyl‑4‑phenyl‑4‑acetoxypiperidine (PEPAP)	2.0	250.0	2.0
227A	3‑Phenylpropanoylfentanyl	0.005	2.5	0.005
228	Pholcodine	5.0	2,500.0	5.0
229	Piminodine	10.0	5,000.0	10.0
230	Pipradrol	1.0	500.0	1.0
231	Piritramide	1.0	500.0	1.0
232	Proheptazine	1.0	500.0	1.0
233	Properidine	25.0	12,500.0	25.0
234	Propiram	10.0	5,000.0	10.0
234A	Protonitazene	0.005	2.5	0.005
234B	Protonitazepyne (N‑pyrrolidino protonitazene)	0.005	2.5	0.005
235	Psilocine	2.0	1,000.0	2.0
236	Psilocybine	2.0	1,000.0	2.0
237	Pyrovalerone	0.75	250.0	0.75
237A	Secofentanyl	0.005	2.5	0.005
238	Tetrahydrocannabinols (THC)	5.0	1,000.0	2.0
239	Thebacon	2.0	250.0	2.0
240	Thebaine	2.0	250.0	2.0
241	Thiofentanyl	0.005	2.5	0.005
241A	Thiofuranylfentanyl	0.005	2.5	0.005
242	Trimeperidine	10.0	5,000.0	10.0
243	2,3,4‑Trimethoxyamphetamine	0.75	250.0	0.75
244	2,3,5‑Trimethoxyamphetamine	0.75	250.0	0.75
245	2,3,6‑Trimethoxyamphetamine	0.75	250.0	0.75
246	2,4,5‑Trimethoxyamphetamine	0.75	250.0	0.75
247	2,4,6‑Trimethoxyamphetamine	0.75	250.0	0.75
248	3,4,5‑Trimethoxyamphetamine	0.75	250.0	0.75
249	2,4,5‑Trimethoxyphenethylamine (2C‑O)	0.5	100.0	0.5

Schedule 2Border controlled drugs

Note: See section 14.

1Border controlled drugs and quantities

(1)
The following table lists substances that are border controlled drugs and the quantities of those drugs that are commercial quantities and marketable quantities.
Note: A drug analogue of a substance listed in the table is also a border controlled drug (see paragraph 301.4(1)(b) of the Code).

Border controlled drugs and quantities
Item	Border controlled drug	Commercial quantity (kilograms)	Marketable quantity (grams)
1	Acetorphine	2.0	2.0
2	Acetyl‑alpha‑methylfentanyl	0.005	0.005
3	Acetylcodeine	2.0	2.0
4	Acetyldihydrocodeine	2.0	2.0
5	Acetylmethadol	2.0	2.0
6	Allylprodine	2.0	2.0
7	Alphacetylmethadol	10.0	10.0
8	Alphameprodine	0.2	0.2
9	Alphamethadol	0.2	0.2
10	alpha‑Methylfentanyl	0.005	0.005
11	alpha‑Methylthiofentanyl	0.005	0.005
12	Alphaprodine	25.0	25.0
13	3‑(2‑Aminopropyl)indole (alpha‑methyltryptamine (AMT))	2.0	2.0
14	5‑(2‑Aminopropyl)‑2,3‑dihydro‑1h‑indene (5‑APDI)	0.75	0.5
15	Amphecloral	2.0	2.0
16	Amphetamine	0.75	2.0
17	Anileridine	25.0	25.0
18	Barbiturates	5.0	50.0
19	Benzethidine	10.0	10.0
20	1‑(Benzofuran‑6‑yl) propan‑2‑amine (6‑APB)	0.75	0.5
20A	Benzoylbenzylfentanyl	0.005	0.005
21	Benzoylecgonine	2.0	2.0
21A	Benzoylfentanyl	0.005	0.005
21B	Benzylfentanyl	0.005	0.005
21C	Benzylfuranylfentanyl	0.005	0.005
22	Benzylmorphine	5.0	5.0
23	Benzylpiperazine	0.75	2.0
24	Betacetylmethadol	5.0	5.0
25	beta‑Hydroxyfentanyl	0.005	0.005
26	beta‑Hydroxy‑3‑methylfentanyl	0.005	0.005
27	beta‑Keto‑N‑methyl‑3,4‑benzodioxyolylbutanamine (butylone)	0.75	2.0
28	Betameprodine	5.0	5.0
29	Betamethadol	5.0	5.0
30	Betaprodine	5.0	5.0
31	Bezitramide	5.0	5.0
31A	Bromazolam	5.0	30.0
32	4‑Bromo‑2,5‑dimethoxyamphetamine	0.5	0.5
33	2‑(4‑bromo‑2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl) methyl]ethanamine (25‑B‑NBOMe)	0.002	0.002
34	Bufotenine	2.0	2.0
34A	Butonitazene	0.005	0.005
35	Cannabinoids (other than a Cannabinoid of a kind that can be obtained from a plant that is not a Cannabis plant)	2.0	2.0
36	Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre)	100.0	25,000.0
37	Cannabis resin	50.0	20.0
38	Cathinone	0.75	2.0
39	1‑(4‑Chloro‑2,5‑dimethoxyphenyl)‑2‑ethenamine (2C‑C)	0.5	0.5
40	2‑(4‑chloro‑2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl) methyl]ethanamine (25‑C‑NBOMe)	0.002	0.002
41	Chlorphentermine	2.0	2.0
42	Clonitazene	0.005	0.005
43	Cocaine	2.0	2.0
44	Codeine	10.0	10.0
45	Codeine‑N‑oxide	10.0	10.0
46	Codoxime	10.0	10.0
46A	N‑Desethyl etonitazene	0.005	0.005
46B	N‑Desethyl isotonitazene	0.005	0.005
46C	N‑Desethyl protonitazene	0.005	0.005
47	Desomorphine	2.0	2.0
48	Dexamphetamine	2.0	2.0
49	Dextromoramide	2.0	2.0
50	Diampromide	5.0	5.0
51	Diethylpropion (N, N‑Diethylcathinone)	5.0	5.0
52	Diethylthiambutene	5.0	5.0
53	N,N‑Diethyltryptamine	2.0	2.0
54	Difenoxin	2.0	2.0
55	Dihydrocodeine	10.0	10.0
56	Dihydromorphine	10.0	10.0
57	Dimenoxadol	10.0	10.0
58	Dimepheptanol	10.0	10.0
59	2,5‑Dimethoxy‑4‑bromophenethylamine (2C‑B)	0.5	0.5
60	2,5‑Dimethoxy‑4‑(n)‑butylthiophenethylamine (2C‑T‑9)	0.5	0.5
61	2,5‑Dimethoxy‑4‑ethylphenethylamine (2C‑E)	0.5	0.5
62	2,5‑Dimethoxy‑4‑ethylthiophenethylamine (2C‑T‑2)	0.5	0.5
63	2,5‑Dimethoxy‑4‑iodophenethylamine (2C‑I)	0.5	0.5
64	2,5‑Dimethoxy‑4‑(β‑isobutylthio)phenethylamine (2C‑T‑17)	0.5	0.5
65	2,5‑Dimethoxy‑4‑isopropylthiophenethylamine (2C‑T‑4)	0.5	0.5
66	2,5‑Dimethoxy‑4‑(β‑methoxyethylthio)phenethylamine (2C‑T‑13)	0.5	0.5
67	2,5‑Dimethoxy‑4‑methylamphetamine (STP, DOM)	0.75	2.0
68	2,5‑Dimethoxy‑4‑methylphenethylamine (2C‑D)	0.5	0.5
69	2,5‑Dimethoxy‑4‑nitrophenethylamine (2C‑N)	0.5	0.5
70	2,5‑Dimethoxy‑4‑(n)‑propylphenethylamine (2C‑P)	0.5	0.5
71	2,5‑Dimethoxy‑4‑n‑propylthiophenethylamine (2C‑T‑7)	0.5	0.5
72	2‑(2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl)methyl] ethanamine (25‑H‑NBOMe)	0.002	0.002
73	1‑Dimethylamino‑1,2‑diphenylethane	5.0	5.0
74	1,1‑Dimethylheptyl‑11‑hydroxytetrahydrocannabinol (HU‑210)	5.0	2.0
75	Dimethylthiambutene	20.0	20.0
76	N,N‑Dimethyltryptamine	2.0	2.0
77	Dioxaphetyl butyrate	2.0	2.0
77A	Dipentylone (N,N‑dimethylpentylone)	0.75	2.0
78	Diphenoxylate	2.0	2.0
79	Dipipanone	10.0	10.0
80	Drotebanol	2.0	2.0
81	Ecgonine	10.0	10.0
82	Ethchlorvynol	50.0	50.0
83	Ethinamate	50.0	50.0
83A	Ethylene etonitazene	0.005	0.005
83B	Ethyleneoxynitazene	0.005	0.005
84	Ethylmethylthiambutene	10.0	10.0
85	Ethylmorphine	2.0	2.0
85A	Etodesnitazene (etazene)	0.005	0.005
86	Etonitazene	0.005	0.005
86A	Etonitazepipne (N‑piperidinyl etonitazene)	0.005	0.005
86B	Etonitazepyne (N‑pyrrolidino etonitazene)	0.005	0.005
87	Etorphine	5.0	5.0
88	Etoxeridine	5.0	5.0
89	Fentanyl	0.005	0.005
89A	Flunitazene	0.005	0.005
89B	2‑Fluorodeschloroketamine (2‑FDCK)	1.0	3.0
90	4‑Fluoro‑2,5‑dimethoxyphenethylamine (2C‑F)	0.5	0.5
91	4‑(2‑Fluoroethylthio)‑2,5‑dimethoxyphenethylamine (2C‑T‑21)	0.5	0.5
92	1‑(5‑fluoropentyl)‑3‑(2‑iodobenzyl)indole (AM‑694)	5.0	2.0
92A	Furanylfentanyl	0.005	0.005
93	Furethidine	1.0	1.0
94	Gammabutyrolactone (GBL)	1.0	2.0
95	Glutethimide	50.0	50.0
96	Harmaline	5.0	2.0
97	Harmine	5.0	2.0
98	Heroin (diacetylmorphine)	1.5	2.0
99	Hydrocodone	2.0	2.0
100	Hydromorphinol	2.0	2.0
101	Hydromorphone	2.0	2.0
102	Hydroxyamphetamine	2.0	2.0
103	4‑Hydroxybutanoic acid (GHB)	1.0	2.0
104	2‑[(1R,3S)‑3‑hydroxycyclohexyl]‑5‑ (2‑methyloctan‑2‑yl)phenol (CP 47,497)	5.0	2.0
105	2‑[(1R,3S)‑3‑hydroxycyclohexyl]‑5‑ (2‑methylnonan‑2‑yl)phenol (CP 47,497‑C8)	5.0	2.0
106	Hydroxypethidine	5.0	5.0
107	2‑(4‑iodo‑2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl) methyl]ethanamine (25‑I‑NBOMe)	0.002	0.002
108	Isomethadone	2.0	2.0
109	4‑Isopropoxy‑2,5‑dimethoxyphenethylamine (2C‑O‑4)	0.5	0.5
109A	Isotodesnitazene	0.005	0.005
109B	Isotonitazene	0.005	0.005
110	Ketamine	1.0	3.0
111	Ketobemidone	2.0	2.0
112	Levomethorphan	2.0	2.0
113	Levophenacylmorphan	2.0	2.0
114	Levorphanol, but not including dextrorphan	1.0	1.0
115	Lysergamide	0.01	0.1
116	Lysergide (LSD)	0.002	0.002
117	Meprobamate	50.0	50.0
118	Mescaline	7.5	7.5
119	Metazocine	7.0	7.0
120	Methadone	2.0	2.0
121	Methamphetamine	0.75	2.0
122	Methaqualone	5.0	50.0
123	Methcathinone	0.75	2.0
124	Methorphan, but not including dextromethorphan	2.0	2.0
125	5‑Methoxy‑alpha‑methyltryptamine (5‑MeO‑AMT)	2.0	2.0
126	4‑Methoxyamphetamine	0.75	2.0
127	5‑Methoxy‑N,N‑diisopropyltryptamine (5‑MeO‑DiPT)	2.0	2.0
128	4‑Methoxymethamphetamine	0.75	2.0
129	2‑(2‑Methoxyphenyl)‑1‑(1‑pentylindol‑3‑yl)ethanone (JWH‑250)	5.0	2.0
130	4‑Methylamphetamine	0.75	2.0
131	Methyldesorphine	2.0	2.0
132	Methyldihydromorphine	2.0	2.0
133	3,4‑Methylenedioxyamphetamine (MDA)	0.75	0.5
134	3,4‑Methylenedioxymethamphetamine (MDMA)	0.5	0.5
134A	Methylenedioxynitazene (2‑(2‑(benzo[d] [1,3]dioxol‑5‑ylmethyl)‑5‑nitro‑1H‑benzo [d]imidazol‑1‑yl)‑N,N‑diethylethan‑1‑amine)	0.005	0.005
135	3,4‑Methylenedioxypyrovalerone (MDPV)	0.75	2.0
136	3‑Methylfentanyl	0.005	0.005
137	4‑Methylmethamphetamine	0.75	2.0
138	4‑Methylmethcathinone (4‑MMC)	0.75	2.0
139	Methylphenidate	2.0	2.0
140	1‑Methyl‑4‑phenyl‑4‑propionoxypiperidine (MPPP)	2.0	2.0
141	4‑Methylthio‑2,5‑dimethoxyphenethylamine (2C‑T)	0.5	0.5
142	4‑Methylthioamphetamine (4‑MTA)	0.75	2.0
143	4‑Methylthiobutylamphetamine (4‑MTBA)	0.75	2.0
144	4‑Methylthiodimethamphetamine (4‑MTDMA)	0.75	2.0
145	4‑Methylthioethylamphetamine (4‑MTEA)	0.75	2.0
146	3‑Methylthiofentanyl	0.005	0.005
147	4‑Methylthiomethamphetamine (4‑MTMA)	0.75	2.0
148	4‑Methylthiopropylamphetamine (4‑MTPA)	0.75	2.0
149	Methyprylon	50.0	50.0
149A	Metodesnitazene (metazene)	0.005	0.005
149B	Metonitazene	0.005	0.005
150	Metopon	2.0	2.0
151	Monoacetylmorphines	2.0	2.0
152	Moramide	2.0	2.0
153	Morphan, but not including dextrorphan	2.0	2.0
154	Morpheridine	2.0	2.0
155	Morphine	1.5	2.0
156	Morphine‑N‑oxide	2.0	2.0
157	(1‑(2‑Morpholin‑4‑ylethyl)indol‑3‑yl)‑napthalen‑1‑ ylmethanone (JWH‑200)	5.0	2.0
158	Myrophine	20.0	20.0
159	Napthalen‑1‑yl‑(1‑butylindol‑3‑yl)methanone (JWH‑073)	5.0	2.0
160	Nicocodine	2.0	2.0
161	Nicodicodine	2.0	2.0
162	Nicomorphine	2.0	2.0
163	Noracymethadol	2.0	2.0
164	Norcodeine	2.0	2.0
165	Norlevorphanol	2.0	2.0
166	Normethadone	5.0	5.0
167	Normorphine	20.0	20.0
168	Norpipanone	10.0	10.0
169	Opium	20.0	20.0
170	Oripavine	2.0	2.0
171	Oxycodone	5.0	5.0
172	Oxymorphone	2.0	2.0
173	para‑Fluorofentanyl	0.005	0.005
174	Pentazocine	20.0	20.0
175	1‑Pentyl‑3‑(1‑napthoyl)indol (JWH‑018)	5.0	2.0
176	1‑Pentyl‑3‑(4‑methyl‑1‑napthoyl)indole (JWH‑122)	5.0	2.0
177	Pethidine	10.0	10.0
178	Phenadoxone	10.0	10.0
179	Phenampromide	10.0	10.0
180	Phenazocine	1.0	1.0
181	Phencyclidine	2.0	2.0
182	Phendimetrazine	5.0	5.0
183	Phenmetrazine	5.0	5.0
184	Phenomorphan	5.0	5.0
185	Phenoperidine	1.0	1.0
186	Phentermine	5.0	5.0
187	1‑Phenylethyl‑4‑phenyl‑4‑acetoxypiperidine (PEPAP)	2.0	2.0
187A	3‑Phenylpropanoylfentanyl	0.005	0.005
188	Pholcodine	5.0	5.0
189	Piminodine	10.0	10.0
190	Pipradrol	1.0	1.0
191	Piritramide	1.0	1.0
192	Proheptazine	1.0	1.0
193	Properidine	25.0	25.0
194	Propiram	10.0	10.0
194A	Protonitazene	0.005	0.005
194B	Protonitazepyne (N‑pyrrolidino protonitazene)	0.005	0.005
195	Psilocine	0.1	0.1
196	Psilocybine	0.1	0.1
197	Pyrovalerone	0.75	2.0
197A	Secofentanyl	0.005	0.005
198	Tetrahydrocannabinols (THC)	5.0	2.0
199	Thebacon	2.0	2.0
200	Thebaine	2.0	2.0
201	Thiofentanyl	0.005	0.005
201A	Thiofuranylfentanyl	0.005	0.005
202	Trimeperidine	10.0	10.0
203	2,3,4‑Trimethoxyamphetamine	0.75	2.0
204	2,3,5‑Trimethoxyamphetamine	0.75	2.0
205	2,3,6‑Trimethoxyamphetamine	0.75	2.0
206	2,4,5‑Trimethoxyamphetamine	0.75	2.0
207	2,4,6‑Trimethoxyamphetamine	0.75	2.0
208	3,4,5‑Trimethoxyamphetamine	0.75	2.0
209	2,4,5‑Trimethoxyphenethylamine (2C‑O)	0.5	0.5

Restricted listing
(2)
The following table lists:
(a)
substances that are taken to be border controlled drugs only in relation to the following:
(i)
an offence against subsection 307.1(1), 307.2(1), 307.3(1) or 307.4(1) of the Code, if the offence relates to importing a substance;
(ii)
an offence against subsection 307.5(1), 307.6(1), 307.7(1), 307.8(1), 307.9(1) or 307.10(1) of the Code;
(iii)
an offence against subsection 309.12(1) or 309.13(1) of the Code, if the offence relates to procuring an individual to import a substance; and
(b)
the quantities of those drugs that are commercial quantities and marketable quantities.
Note: For a drug analogue of a substance listed in the table, see paragraph 301.4(1)(b) and subsection 301.4(3) of the Code.

Border controlled drugs and quantities—restricted listing
Item	Border controlled drug	Commercial quantity (kilograms)	Marketable quantity (grams)
1	1,4‑Butanediol (1,4‑BD)	1.0	2.0

Endnotes

Endnote 1About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Editorial changes

The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.

If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe how an amendment is to be made. If, despite the misdescription, the amendment can be given effect as intended, then the misdescribed amendment can be incorporated through an editorial change made under section 15V of the Legislation Act 2003.

If a misdescribed amendment cannot be given effect as intended, the amendment is not incorporated and “(md not incorp)” is added to the amendment history.

Endnote 2Abbreviation key

ad = added or inserted	o = order(s)
am = amended	Ord = Ordinance
amdt = amendment	orig = original
c = clause(s)	par = paragraph(s)/subparagraph(s)
C[x] = Compilation No. x	/sub‑subparagraph(s)
Ch = Chapter(s)	pres = present
def = definition(s)	prev = previous
Dict = Dictionary	(prev…) = previously
disallowed = disallowed by Parliament	Pt = Part(s)
Div = Division(s)	r = regulation(s)/rule(s)
ed = editorial change	reloc = relocated
exp = expires/expired or ceases/ceased to have	renum = renumbered
effect	rep = repealed
F = Federal Register of Legislation	rs = repealed and substituted
gaz = gazette	s = section(s)/subsection(s)
LA = Legislation Act 2003	Sch = Schedule(s)
LIA = Legislative Instruments Act 2003	Sdiv = Subdivision(s)
(md) = misdescribed amendment can be given	SLI = Select Legislative Instrument
effect	SR = Statutory Rules
(md not incorp) = misdescribed amendment	Sub‑Ch = Sub‑Chapter(s)
cannot be given effect	SubPt = Subpart(s)
mod = modified/modification	underlining = whole or part not
No. = Number(s)	commenced or to be commenced

Endnote 3Legislation history

Name	Registration	Commencement	Application, saving and transitional provisions
Criminal Code Regulations 2019	8 Apr 2019 (F2019L00561)	9 Apr 2019 (s 2(1) item 1)
Criminal Code and Customs Legislation Amendment (Precursors and Drugs) Regulations 2020	10 Aug 2020 (F2020L01003)	Sch 1 (items 1–12): 12 Aug 2020 (s 2(1) item 1)	—
Counter‑Terrorism Legislation Amendment (High Risk Terrorist Offenders) Regulations 2021	20 Dec 2021 (F2021L01842)	Sch 1 (item 1): 21 Dec 2021 (s 2(1) item 1)	—
Crimes Legislation Amendment (Community Safety Orders and Other Measures) Regulations 2023	7 Dec 2023 (F2023L01628)	Sch 1 (items 1–5): 8 Dec 2023 (s 2(1) item 1)	—
Criminal Code Amendment (Border Controlled Drugs and Precursors) Regulations 2024	29 Feb 2024 (F2024L00249)	1 Mar 2024 (s 2(1) item 1)	Sch 1 (item 10)
Criminal Code Amendment (Controlled and Border Controlled Drugs and Precursors) Regulations 2025	24 Jan 2025 (F2025L00032)	1 Mar 2025 (s 2(1) item 1)	—

Endnote 4Amendment history

Provision affected	How affected
Part 1
s 2.............................................	rep LA s 48D
Part 2
Division 3
s 10............................................	am F2021L01842; F2023L01628
Part 3
Division 1
s 13............................................	am F2020L01003; F2025L00032
s 14............................................	am F2024L00249
s 15............................................	am F2024L00249
s 16............................................	am F2020L01003; F2024L00249; F2025L00032
Division 4
Division 4..................................	ad F2023L01628
s 20A.........................................	ad F2023L01628
s 20B.........................................	ad F2023L01628
Schedule 1
c 1.............................................	am F2025L00032
Schedule 2
c 1.............................................	am F2024L00249; F2025L00032